JIC
IDXX icon

Johnson Investment Counsel’s Idexx Laboratories IDXX Stock Holding History

Johnson Investment Counsel’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-635
Closed -$395K – 674
2021
Q3 		$395K Buy
635
+35
+6% +$23.5K 0.01% 489
2021
Q2 		$379K Buy
600
+13
+2% +$7.18K 0.01% 492
2021
Q1 		$287K Buy
+587
New +$294K ﹤0.01% 514

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Johnson Investment Counsel's IDXX Position: Q4 2021 in Review

Johnson Investment Counsel sold out of Idexx Laboratories (IDXX) in Q4 2021, closing a stake of 635 shares — an estimated $395K sold.

Johnson Investment Counsel first reported a position in IDXX in Q1 2021 and held it in 3 quarters. The position peaked at $395K in Q3 2021. 1,107 funds tracked by Wall St. Rank hold IDXX as of Q4 2021.

  • Johnson Investment Counsel reported no remaining Idexx Laboratories position as of Q4 2021 after selling out during the quarter.
  • Johnson Investment Counsel sold 635 Idexx Laboratories shares in Q4 2021, an estimated $395K.
  • Johnson Investment Counsel first reported a position in Idexx Laboratories in Q1 2021 and held it in 3 quarters.
  • Johnson Investment Counsel's Idexx Laboratories position peaked at $395K in Q3 2021.
  • 1,107 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2021.

Based on Johnson Investment Counsel's 13F filing for Q4 2021, filed 15 Feb 2022.